Entity Common Stock, Shares Outstanding of Matinas BioPharma Holdings, Inc. from 14 May 2014 to 06 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Matinas BioPharma Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 14 May 2014 to 06 Nov 2025.
  • Matinas BioPharma Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 06 Nov 2025 was 6,406,191, a 26% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Matinas BioPharma Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 6,406,191 +1,319,206 +26% 06 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 5,086,985 -245,729,179 -98% 12 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 5,086,985 -212,395,845 -98% 15 Apr 2025 10-K 15 Apr 2025 2024 FY
Q3 2024 5,086,985 -212,177,541 -98% 13 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 250,816,164 +33,551,638 +15% 09 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 217,482,830 +218,304 +0.1% 18 Mar 2024 10-K 27 Mar 2024 2023 FY
Q3 2023 217,264,526 +400,000 +0.18% 03 Nov 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 217,264,526 +400,000 +0.18% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 217,264,526 +400,000 +0.18% 03 Mar 2023 10-K 15 Mar 2023 2022 FY
Q3 2022 216,864,526 +616,998 +0.28% 31 Oct 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 216,864,526 +2,123,104 +0.99% 08 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 216,864,526 +12,588,114 +6.2% 04 Mar 2022 10-K/A 11 Mar 2022 2021 FY
Q3 2021 216,247,528 +16,997,770 +8.5% 04 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 214,741,422 +15,867,945 +8% 05 Aug 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 204,276,412 +7,719,549 +3.9% 24 Mar 2021 10-K 29 Mar 2021 2020 FY
Q3 2020 199,249,758 +36,509,484 +22% 03 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 198,873,477 +36,466,187 +22% 06 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 196,556,863 +53,619,237 +38% 03 Mar 2020 10-K 09 Mar 2020 2019 FY
Q3 2019 162,740,274 +50,354,684 +45% 11 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 162,407,290 +67,830,899 +72% 09 Aug 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 142,937,626 +49,459,024 +53% 29 Mar 2019 10-K 01 Apr 2019 2018 FY
Q3 2018 112,385,590 +19,435,494 +21% 06 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 94,576,391 +2,604,068 +2.8% 06 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 93,478,602 +4,423,275 +5% 02 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 92,950,096 +34,901,684 +60% 10 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 91,972,323 07 Aug 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 89,055,327 +31,875,179 +56% 15 Mar 2017 10-K 31 Mar 2017 2016 FY
Q3 2016 58,048,412 +841,077 +1.5% 11 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q1 2016 57,180,148 +20,279,478 +55% 01 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 57,207,335 +25,039,685 +78% 10 Nov 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 56,967,690 +24,967,690 +78% 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 36,900,670 +4,900,670 +15% 20 Mar 2015 10-K 31 Mar 2015 2014 FY
Q3 2014 32,167,650 14 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 32,000,000 08 Aug 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 32,000,000 14 May 2014 10-Q 06 Jun 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.